Serological Diagnostics of Lyme Borreliosis: Comparison of Universal and Borrelia Species-Specific Tests Based on Whole-Cell and Recombinant Antigens Immunoassays

The study compares diagnostic parameters of different commercial serological kits based on three different antigen types and correlates test results with the status of the patient's Borrelia infection. In total, 8 IgM and 8 IgG kits were tested, as follows: enzyme-linked immunosorbent assay (ELISA) (Euroimmun) based on whole-cell antigen, 3 species-specific enzyme immunoassays (EIAs) (TestLine), Liaison chemiluminescence (DiaSorin), ELISA-Viditest (Vidia), EIA, and Blot-Line (TestLine) using recombinant antigens. All tests were performed on a panel of 90 samples from patients with clinically characterized borreliosis (53 with neuroborreliosis, 32 with erythema migrans, and 5 with arthritis) plus 70 controls from blood donors and syphilis patients. ELISA based on whole-cell antigens has superior sensitivity and superior negative predictive value and serves as an excellent screening test, although its specificity and positive predictive values are low. Species-specific tests have volatile parameters. Their low sensitivity and low negative predictive value handicap them in routine diagnostics. Tests with recombinant antigens are characterized by high specificity and high positive predictive value and have a wide range of use in diagnostic practice. Diagnostic parameters of individual tests depend on the composition of the sample panel. Only a small proportion of contradictory samples giving both negative and positive results is responsible for discrepancies between test results....
Source: Journal of Clinical Microbiology - Category: Microbiology Authors: Tags: Immunoassays Source Type: research

Related Links:

Public health officials are grappling with climbing rates of syphilis and drug use in the US, as two public health crises collide.Kaiser Health News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Drug maker Abbvie made over $18 billion on it's arthritis drug, Humira, in 2017. It has kept a monopoly on the drug by making tiny changes to the formula, which costs over $5,600 in the US.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
RHEUMATOID arthritis is the second most common type of arthritis in the UK. The condition is incurable, but pain and symptoms can be reduced by including certain vitamins and minerals that are beneficial to joint health. Here are three to ensure you include in your diet if you have arthritis.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Conditions:   Musculoskeletal Infection;   Acute Hematogenous Osteomyelitis;   Septic Arthritis;   Osteomyelitis;   Pyomyositis Intervention:   Diagnostic Test: Karius Test Sponsors:   Indiana University;   Karius, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionThese results together with the literature data reinforce the anti-hypersensitivity and anti-inflammatory activity of A. moluccanus extract. Part of the observed effects is due to the presence of the compound 2″-O-rhamnosylswertisin. The fact that the extract acted as a disease modifier point this herbal product as a promisor and safe tool to treat RA and other associated chronic diseases.Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
Could joint ultrasonography help identify which patients with arthralgia may be at risk of developing arthritis?Arthritis Research &Therapy
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Tags: Letter Source Type: research
"Who knew there would be so much interest in a biomechanics paper??!!" Those are the words--and the multiple exclamation points--of Tara Moriarty, proprietor of the Moriarty Lab, an infectious diseases research lab that studies primarily Borrelia burgdorferi (Bb) the bacterium that causes Lyme disease. Moriarty is the principal investigator of a new academic paper from the University of Toronto that details the mechanism by which Bb "crawl" through the body. Scientific American is among the many mainstream outlets that discussed the findings, which may represent a major step in making t...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Late last month, FOX5NY broadcast "Lyme and Reason," a precedent-setting news special dedicated to the Lyme disease epidemic. The show was a success by many measures, including--most importantly by TV production standards--ratings wise. The strong viewership reflects a strong interest in learning more about Lyme disease. More and more, people are discovering that they know someone whose life has been profoundly affected by Lyme. More and more, people are discovering that they themselves have been living with undiagnosed Lyme for years. Now the FOX5NY team is calling on the U.S. Centers for Disease Control and pr...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Today, the Boston Globe editorial board spoke out against a bill "that would require insurers in Massachusetts to cover Lyme disease treatments for as long as a doctor says they're needed." The Globe writes: Lawmakers may have good intentions, but they don't possess the expertise to decide whether it's beneficial, cost-efficient, or safe, to keep using strong medicines to treat a condition the medical establishment doubts is real. Such questions should be resolved by a consensus of doctors and researchers -- and buttressed by convincing clinical date [sic] -- not determined by legislative mandate. Who among the B...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
More News: Arthritis | Borrelia | Brain | Chemistry | Lyme Disease | Microbiology | Neurology | Rheumatology | Study | Syphilis